---
title: "Bluejay Diagnostics Raises $7.7 Million in Private Placement, Issues Pre-Funded and 5-Year Warrants"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/289105229.md"
description: "Bluejay Diagnostics completed a $7.7 million private placement on June 5, 2026, selling pre-funded and Series G/H warrants at $2.324 per unit. H.C. Wainwright served as placement agent. The company also entered a resale registration rights agreement to facilitate investor liquidity for the warrant shares."
datetime: "2026-06-08T21:23:00.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/289105229.md)
  - [en](https://longbridge.com/en/news/289105229.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/289105229.md)
---

# Bluejay Diagnostics Raises $7.7 Million in Private Placement, Issues Pre-Funded and 5-Year Warrants

Bluejay Diagnostics completed a private placement, entering a securities purchase agreement and a related registration rights agreement with institutional accredited investors. The offering, which closed on June 5, 2026, generated approximately $7.7 million in net proceeds and included pre-funded warrants and Series G and H warrants, with unit pricing at $2.324 and warrant exercise prices of $0.0001 (pre-funded) and $2.075 (Series G/H). H.C. Wainwright acted as placement agent and received cash fees and placement agent warrants. The company agreed to file and maintain a resale registration to facilitate investor liquidity.

**Agreement 1: Bluejay Diagnostics Closes $7.7 Million Private Placement of Pre-Funded and Common Warrants**

-   **Agreement type**: Securities purchase agreement for private placement of pre-funded and common warrants
-   **Counterparty**: Institutional Accredited Investors
-   **Signed / Effective**: Jun 02 2026 / Jun 05 2026
-   **Duration / Termination**: At will
-   **Reason**: Raise capital with warrant coverage

**Agreement 2: Bluejay Diagnostics Enters Resale Registration Rights Agreement for Warrant Shares**

-   **Agreement type**: Registration rights agreement for resale of warrant shares
-   **Counterparty**: Institutional Accredited Investors
-   **Signed / Effective**: Jun 02 2026 / Jun 02 2026
-   **Duration / Termination**: Until all shares can be sold or under Rule 144
-   **Reason**: Provide liquidity for investors via registered resale

Original SEC Filing: Bluejay Diagnostics, Inc. \[ BJDX \] - 8-K - Jun. 08, 2026

**Disclaimer**

This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.

### Related Stocks

- [BJDX.US](https://longbridge.com/en/quote/BJDX.US.md)

## Related News & Research

- [Bluejay Diagnostics Unveils Private Placement Up To $23.6 Mln; Stock Down](https://longbridge.com/en/news/288522165.md)
- [Bluejay Diagnostics Announces up to $23.6 Million Private Placement Priced At-the-Market Under Nasdaq Rules | BJDX Stock News](https://longbridge.com/en/news/288455979.md)
- [PowerFleet Q4 2026 Earnings Preview](https://longbridge.com/en/news/289616465.md)
- [Goldman Sachs projects S&P 500 to reach 8,000 by 2026](https://longbridge.com/en/news/289661631.md)
- [Zedge Q3 2026 Earnings Preview](https://longbridge.com/en/news/289381005.md)